TEN
Tenax Therapeut
Stock
Stock
ISIN: US88032L6056
Ticker: TENX
US88032L6056
TENX
Price
Price
CHART BY
Frequently asked questions
What is Tenax Therapeut's market capitalization?
The market capitalization of Tenax Therapeut is $19.12M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Tenax Therapeut?
Tenax Therapeut's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$15.94. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Tenax Therapeut's stock?
Currently, 4 analysts cover Tenax Therapeut's stock, with a consensus target price of $20.67. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Tenax Therapeut?
Tenax Therapeut's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$15.53M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Tenax Therapeut?
Tenax Therapeut has a free cash flow of -$12.46M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Tenax Therapeut have, and what sector and industry does it belong to?
Tenax Therapeut employs approximately 5 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Tenax Therapeut's shares?
The free float of Tenax Therapeut is 2.98M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $19.12M
- EPS (TTM)
- -$15.94
- Free Float
- 2.98M
- EBITDA (TTM)
- -$15.53M
- Free Cashflow (TTM)
- -$12.46M
Pricing
- 52W span
- $0.252$21.41
Analyst Ratings
The price target is $20.67 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
- Employees
- 5
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US88032L6056
- Primary Ticker
- TENX